- Is Active Surveillance Best?
- National Institute for Health and Care Excellence (NICE) Does Not Recommend Olaparib for Patients with Certain Prostate Cancers
- PSMA-PET Imaging Disrupts Prostate Cancer Paradigm
- Adding Apalutamide to ADT Effective in High-Risk Biochemically Recurrent Prostate Cancer
- Scientists Find a New Possible Target for Metastatic Prostate Cancer